190 related articles for article (PubMed ID: 28349284)
21. p53: functions, mutations and sarcomas.
Hung J; Anderson R
Acta Orthop Scand Suppl; 1997 Feb; 273():68-73. PubMed ID: 9057590
[TBL] [Abstract][Full Text] [Related]
22. [P53 genes and solid tumors].
Theillet C
Bull Cancer; 1993 Aug; 80(8):693-6. PubMed ID: 8204950
[TBL] [Abstract][Full Text] [Related]
23. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
[TBL] [Abstract][Full Text] [Related]
24. Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection.
Glazko GV; Koonin EV; Rogozin IB
Biochim Biophys Acta; 2004 Aug; 1679(2):95-106. PubMed ID: 15297143
[TBL] [Abstract][Full Text] [Related]
25. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
26. Absence of p53 germ-line mutations in bilateral breast cancer patients.
Lidereau R; Soussi T
Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
[TBL] [Abstract][Full Text] [Related]
27. P53 gene mutations: case study of a clinical marker for solid tumors.
Liu MC; Gelmann EP
Semin Oncol; 2002 Jun; 29(3):246-57. PubMed ID: 12063677
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical importance of the p53 tumor suppressor gene.
Velculescu VE; El-Deiry WS
Clin Chem; 1996 Jun; 42(6 Pt 1):858-68. PubMed ID: 8665676
[TBL] [Abstract][Full Text] [Related]
29. p53 gain-of-function: tumor biology and bioinformatics come together.
Koonin EV; Rogozin IB; Glazko GV
Cell Cycle; 2005 May; 4(5):686-8. PubMed ID: 15846083
[TBL] [Abstract][Full Text] [Related]
30. TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier M; Hollstein M; Hainaut P
Cold Spring Harb Perspect Biol; 2010 Jan; 2(1):a001008. PubMed ID: 20182602
[TBL] [Abstract][Full Text] [Related]
31. p53: 800 million years of evolution and 40 years of discovery.
Levine AJ
Nat Rev Cancer; 2020 Aug; 20(8):471-480. PubMed ID: 32404993
[TBL] [Abstract][Full Text] [Related]
32. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
33. FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.
Smardová J
Neoplasma; 1999; 46(2):80-8. PubMed ID: 10466430
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional functionality of germ line p53 mutants influences cancer phenotype.
Monti P; Ciribilli Y; Jordan J; Menichini P; Umbach DM; Resnick MA; Luzzatto L; Inga A; Fronza G
Clin Cancer Res; 2007 Jul; 13(13):3789-95. PubMed ID: 17606709
[TBL] [Abstract][Full Text] [Related]
35. Computer program for the analysis of mutational spectra: application to p53 mutations.
Cariello NF; Piegorsch WW; Adams WT; Skopek TR
Carcinogenesis; 1994 Oct; 15(10):2281-5. PubMed ID: 7955067
[TBL] [Abstract][Full Text] [Related]
36. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
[TBL] [Abstract][Full Text] [Related]
37. Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.
Zhou R; Xu A; Gingold J; Strong LC; Zhao R; Lee DF
Trends Pharmacol Sci; 2017 Oct; 38(10):908-927. PubMed ID: 28818333
[TBL] [Abstract][Full Text] [Related]
38. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
Wu CC; Shete S; Amos CI; Strong LC
Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
[TBL] [Abstract][Full Text] [Related]
39. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
40. p53: out of Africa.
Lane D
Genes Dev; 2016 Apr; 30(8):876-7. PubMed ID: 27083994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
